Pfizer Ltd
Nifty 500
Smallcap 250
₹4,060.20
-0.86%
Delayed · cached 15 min
Fair value analysis
PFIZER
Pfizer Ltd
₹4,095.40
Close used for this calculation
₹2,578.61Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
60/100
Quality radar
Consensus fair value
₹2,578.61
Above FV▼ -37.0% against the close used
Model range ₹932.20 – ₹4,521.14
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹932.20Fair value₹2,578.61Bull₹4,521.14
FairClose
52-week traded range
52W low ₹4,095.4052W high ₹5,529.50
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Pfizer Ltd closed at ₹4,095.40, 58.8% above the consensus fair value of ₹2,578.61 drawn from 7 valuation models.
Financial DNA score 60/100 — Good. P/E of 121.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹932.20
-77.2%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Formula
₹4,521.14
+10.4%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹3,583.92
-12.5%
EPS × 35.7x (sector P/E)
EPS=100.39, Sector P/E=35.7x
Peter Lynch (PEG)
₹2,509.75
-38.7%
EPS × Growth% (PEG = 1 is fair)
EPS=100.39, g=25%
Dividend Discount (DDM)
₹4,091.30
-0.1%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=75.76, r=10%, g=8%
Reverse DCF
₹4,095.40
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 16.8% | Historical: 25%
Margin of Safety
₹2,259.32
-44.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3012.42, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.